1. May, Halie J, Jeong, Jaehoon, Revah-Politi, Anya, Roche, Katherine W, Anyane-Yeboa, Kwame. 2021. Truncating variants in the SHANK1 gene are associated with a spectrum of neurodevelopmental disorders. In Genetics in medicine : official journal of the American College of Medical Genetics, 23, 1912-1921. doi:10.1038/s41436-021-01222-w. https://pubmed.ncbi.nlm.nih.gov/34113010/
2. Gong, XiaoHong, Wang, HongYan. . SHANK1 and autism spectrum disorders. In Science China. Life sciences, 58, 985-90. doi:10.1007/s11427-015-4892-6. https://pubmed.ncbi.nlm.nih.gov/26335738/
3. Wang, Tianyun, Guo, Hui, Xiong, Bo, Xia, Kun, Eichler, Evan E. 2016. De novo genic mutations among a Chinese autism spectrum disorder cohort. In Nature communications, 7, 13316. doi:10.1038/ncomms13316. https://pubmed.ncbi.nlm.nih.gov/27824329/
4. Monteiro, Patricia, Feng, Guoping. 2017. SHANK proteins: roles at the synapse and in autism spectrum disorder. In Nature reviews. Neuroscience, 18, 147-157. doi:10.1038/nrn.2016.183. https://pubmed.ncbi.nlm.nih.gov/28179641/
5. Qin, Yue, Du, Yasong, Chen, Liqiang, Gong, Xiaohong, Wang, Hongyan. 2022. A recurrent SHANK1 mutation implicated in autism spectrum disorder causes autistic-like core behaviors in mice via downregulation of mGluR1-IP3R1-calcium signaling. In Molecular psychiatry, 27, 2985-2998. doi:10.1038/s41380-022-01539-1. https://pubmed.ncbi.nlm.nih.gov/35388181/
6. Loi, Eleonora, Moi, Loredana, Fadda, Antonio, Cocco, Pierluigi, Zavattari, Patrizia. 2019. Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia. In Oncotarget, 10, 4987-5002. doi:10.18632/oncotarget.27080. https://pubmed.ncbi.nlm.nih.gov/31452839/
智鼠故事 
